Copyright
©The Author(s) 2024.
World J Gastroenterol. Jul 14, 2024; 30(26): 3221-3228
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3221
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3221
Ref. | Selected population | Type of study | Patients (n) | Endpoint | Significant results |
Yao et al[26] | Patients on GLP-1 RAs (cases) and patients not taking GLP-1 RAs (controls) | Retrospective cohort study | 446 | Comparing bowel prep quality using the BBPS between diabetic patients taking GLP-1 RAs (case group) and diabetic patients not on GLP-1 As (control group) | BBPS score of < 5 was 15.5% in the case group vs 6.6 in the control group. 18.9% of the case group needed repeat colonoscopy as compared to 11.1% in the control group |
Tong et al[27] | Patients on liraglutide vs patients on sitagliptin vs patients not on GLP-1 RAs | Prospective observational study | 360 | Assess the incidence of inadequate bowel cleaning using the BBPS, in patients taking GLP-1 RAs vs DPP-4i vs patients not taking GLP-1 RA | No statistical significance in the incidence of inadequate bowel cleaning was found between the liraglutide group, the sitagliptin group, and the control group P = 0.927. Patients with Type 2 Diabetes and peripheral neuropathy taking GLP-1 RA did have a significant increase in inadequate bowel cleaning when compared to the sitagliptin group (61.3% vs 32.1%, P = 0.022) and control group (61.3% vs 32.8%, P = 0.025) |
Sharma et al[28] | Patients aged 45-75 who had an outpatient elective colonoscopy between 2012 and 2015, took one of the following drugs–Byetta, Victoza, or Bydureon | Retrospective medical record analysis | 255 | Comparing bowel prep quality using high-volume polyethylene glycol electrolyte lavage solution among two groups, one taking a GLP-1 RA and other group not taking a GLP-1 RA | The percentage of satisfactory bowel preparations in the group taking a GLP-1 RA was 92.06% and 92.25% in the group not taking a GLP-1 RA |
- Citation: Ghazanfar H, Javed N, Qasim A, Sosa F, Altaf F, Khan S, Mahasamudram J, Jyala A, Kandhi SD, Shin D, Mantri N, Sun H, Hanumanthu S, Patel H, Makker J, Balar B, Dev A, Chilimuri S. Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study. World J Gastroenterol 2024; 30(26): 3221-3228
- URL: https://www.wjgnet.com/1007-9327/full/v30/i26/3221.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i26.3221